Symbols / LH Stock $264.92 -2.82% Labcorp Holdings Inc.

Healthcare • Diagnostics & Research • United States • NYQ
LH (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, the company offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI-enabled Test Selection, a generative AI-enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. The company has a strategic collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics. The company was founded in 1995 and is headquartered in Burlington, North Carolina.

Stock Fundamentals
Scroll to Statements
Market Cap 21.83B Enterprise Value 27.84B Income 876.50M Sales 13.95B Book/sh 104.86 Cash/sh 6.46
Dividend Yield 1.09% Payout 27.53% Employees 61770 IPO — P/E 25.33 Forward P/E 13.74
PEG 1.12 P/S 1.56 P/B 2.53 P/C — EV/EBITDA 12.70 EV/Sales 2.00
Quick Ratio 0.99 Current Ratio 1.42 Debt/Eq 75.56 LT Debt/Eq — EPS (ttm) 10.46 EPS next Y 19.29
EPS Growth 15.70% Revenue Growth 5.60% Earnings 2026-04-30 ROA 5.12% ROE 10.51% ROIC —
Gross Margin 28.76% Oper. Margin 10.55% Profit Margin 6.28% Shs Outstand 82.19M Shs Float 82.00M Short Float 3.90%
Short Ratio 5.83 Short Interest — 52W High 293.72 52W Low 218.76 Beta 0.98 Avg Volume 638.52K
Volume 816.95K Target Price $310.06 Recom Buy Prev Close $272.62 Price $264.92 Change -2.82%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$310.06
Mean price target
2. Current target
$264.92
Latest analyst target
3. DCF / Fair value
$211.70
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$264.92
Low
$270.00
High
$347.00
Mean
$310.06

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-08 main Evercore ISI Group Outperform → Outperform $300
2026-02-24 main Piper Sandler Neutral → Neutral $300
2026-02-18 main JP Morgan Overweight → Overweight $330
2026-02-18 main Baird Outperform → Outperform $326
2026-02-06 main JP Morgan Overweight → Overweight $319
2025-11-07 main JP Morgan Overweight → Overweight $317
2025-10-29 main UBS Buy → Buy $320
2025-10-17 main UBS Buy → Buy $325
2025-10-17 main Mizuho Outperform → Outperform $320
2025-10-03 main Evercore ISI Group Outperform → Outperform $305
2025-10-02 main Barclays Equal-Weight → Equal-Weight $290
2025-07-25 main Truist Securities Buy → Buy $310
2025-07-25 main UBS Buy → Buy $305
2025-07-25 main Evercore ISI Group Outperform → Outperform $300
2025-07-25 main Morgan Stanley Overweight → Overweight $306
2025-07-25 main Baird Outperform → Outperform $302
2025-07-18 main UBS Buy → Buy $282
2025-07-09 main Evercore ISI Group Outperform → Outperform $285
2025-06-25 main Barclays Equal-Weight → Equal-Weight $275
2025-06-11 main Morgan Stanley Overweight → Overweight $283
News
RSS: Latest LH news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-27 WILKINSON PETER J Officer — 1,633 $267.05 $436,093
2026-03-27 MELTZER JONATHAN C Officer — 839 $267.05 $224,055
2026-03-26 VAN DER VAART SANDRA DILLARD Officer — 6,382 $0.00 $0
2026-03-26 CAVENEY BRIAN J Officer — 11,290 $0.00 $0
2026-03-26 SCHECHTER ADAM H Chief Executive Officer — 58,470 $0.00 $0
2026-03-26 WILKINSON PETER J Officer — 2,388 $0.00 $0
2026-03-26 GRAHAM ANITA Z Officer — 6,604 $0.00 $0
2026-03-26 SCHROEDER MARK S Chief Operating Officer — 12,272 $0.00 $0
2026-03-26 SUMMY AMY B Officer — 3,994 $0.00 $0
2026-03-26 BAILEY MEGAN D Officer — 1,184 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
13,951.70
+7.25%
13,008.90
+6.97%
12,161.60
+2.51%
11,863.90
Operating Revenue
13,974.70
+6.95%
13,066.90
+7.44%
12,161.60
+2.51%
11,863.90
Cost Of Revenue
9,939.20
+5.91%
9,384.50
+6.68%
8,796.70
+7.87%
8,155.00
Reconciled Cost Of Revenue
9,538.10
+6.01%
8,997.40
+6.61%
8,439.20
+8.04%
7,811.40
Gross Profit
4,012.50
+10.71%
3,624.40
+7.71%
3,364.90
-9.27%
3,708.90
Operating Expense
2,496.30
+0.40%
2,486.40
+10.94%
2,241.20
+14.54%
1,956.70
Selling General And Administration
2,216.30
-0.61%
2,230.00
+10.32%
2,021.40
+14.65%
1,763.10
Total Expenses
12,435.50
+4.76%
11,870.90
+7.55%
11,037.90
+9.16%
10,111.70
Operating Income
1,516.20
+33.23%
1,138.00
+1.27%
1,123.70
-35.87%
1,752.20
Total Operating Income As Reported
1,384.70
+27.42%
1,086.70
+49.77%
725.60
-49.49%
1,436.50
EBITDA
2,012.70
+11.12%
1,811.30
+34.59%
1,345.80
-31.14%
1,954.40
Normalized EBITDA
2,129.00
+15.69%
1,840.30
+7.30%
1,715.10
-24.20%
2,262.60
Reconciled Depreciation
681.10
+5.84%
643.50
+11.47%
577.30
+7.46%
537.20
EBIT
1,331.60
+14.03%
1,167.80
+51.96%
768.50
-45.77%
1,417.20
Total Unusual Items
-116.30
-301.03%
-29.00
+92.15%
-369.30
-19.82%
-308.20
Total Unusual Items Excluding Goodwill
-116.30
-301.03%
-29.00
+92.15%
-369.30
-19.82%
-308.20
Special Income Charges
-131.50
-156.34%
-51.30
+87.11%
-398.10
-26.10%
-315.70
Impairment Of Capital Assets
4.30
-18.87%
5.30
-98.48%
349.00
+33.36%
261.70
Restructuring And Mergern Acquisition
127.20
+176.52%
46.00
-6.31%
49.10
-9.07%
54.00
Net Income
876.50
+17.49%
746.00
+78.47%
418.00
-67.32%
1,279.10
Pretax Income
1,107.50
+15.42%
959.50
+68.66%
568.90
-54.02%
1,237.40
Net Non Operating Interest Income Expense
-224.10
-7.59%
-208.30
-4.36%
-199.60
-11.01%
-179.80
Interest Expense Non Operating
224.10
+7.59%
208.30
+4.36%
199.60
+11.01%
179.80
Net Interest Income
-224.10
-7.59%
-208.30
-4.36%
-199.60
-11.01%
-179.80
Interest Expense
224.10
+7.59%
208.30
+4.36%
199.60
+11.01%
179.80
Other Income Expense
-184.60
-719.46%
29.80
+108.39%
-355.20
-6.03%
-335.00
Other Non Operating Income Expenses
-55.00
-191.36%
60.20
+288.39%
15.50
+148.14%
-32.20
Gain On Sale Of Security
15.20
-31.84%
22.30
-22.57%
28.80
+284.00%
7.50
Tax Provision
229.80
+8.19%
212.40
+12.68%
188.50
-19.41%
233.90
Tax Rate For Calcs
0.00
-6.33%
0.00
-33.23%
0.00
+75.11%
0.00
Tax Effect Of Unusual Items
-24.07
-275.63%
-6.41
+94.76%
-122.24
-109.82%
-58.26
Net Income Including Noncontrolling Interests
877.70
+17.48%
747.10
+78.22%
419.20
-67.27%
1,280.60
Net Income From Continuing Operation Net Minority Interest
876.50
+17.49%
746.00
+96.73%
379.20
-62.16%
1,002.00
Net Income From Continuing And Discontinued Operation
876.50
+17.49%
746.00
+78.47%
418.00
-67.32%
1,279.10
Net Income Continuous Operations
877.70
+17.48%
747.10
+96.40%
380.40
-62.09%
1,003.50
Net Income Discontinuous Operations
0.00
0.00
-100.00%
38.80
-86.00%
277.10
Minority Interests
-1.20
-9.09%
-1.10
+8.33%
-1.20
+20.00%
-1.50
Normalized Income
968.73
+26.04%
768.59
+22.73%
626.26
-49.98%
1,251.94
Net Income Common Stockholders
876.50
+17.49%
746.00
+78.47%
418.00
-67.32%
1,279.10
Diluted EPS
10.46
+18.33%
8.84
+85.32%
4.77
-65.86%
13.97
Basic EPS
10.54
+18.56%
8.89
+85.21%
4.80
-65.84%
14.05
Basic Average Shares
83.20
-0.83%
83.90
-3.67%
87.10
-4.39%
91.10
Diluted Average Shares
83.80
-0.71%
84.40
-3.65%
87.60
-4.37%
91.60
Diluted NI Availto Com Stockholders
876.50
+17.49%
746.00
+78.47%
418.00
-67.32%
1,279.10
Amortization
280.00
+9.20%
256.40
+16.65%
219.80
+13.53%
193.60
Amortization Of Intangibles Income Statement
280.00
+9.20%
256.40
+16.65%
219.80
+13.53%
193.60
Depreciation Amortization Depletion Income Statement
280.00
+9.20%
256.40
+16.65%
219.80
+13.53%
193.60
Depreciation And Amortization In Income Statement
280.00
+9.20%
256.40
+16.65%
219.80
+13.53%
193.60
Earnings From Equity Interest
-13.30
-850.00%
-1.40
+0.00%
-1.40
-125.93%
5.40
Line Item Trend 2023-12-31
Total Assets
16,725.10
Current Assets
3,765.40
Cash Cash Equivalents And Short Term Investments
536.80
Cash And Cash Equivalents
536.80
Receivables
2,098.70
Accounts Receivable
1,913.30
Gross Accounts Receivable
1,946.00
Allowance For Doubtful Accounts Receivable
-32.70
Other Receivables
185.40
Inventory
474.60
Raw Materials
474.60
Prepaid Assets
—
Assets Held For Sale Current
0.00
Other Current Assets
655.30
Total Non Current Assets
12,959.70
Net PPE
2,911.80
Gross PPE
5,816.90
Accumulated Depreciation
-2,905.10
Properties
0.00
Land And Improvements
98.80
Buildings And Improvements
1,083.80
Machinery Furniture Equipment
3,039.20
Construction In Progress
342.20
Other Properties
737.10
Leases
515.80
Goodwill And Other Intangible Assets
9,484.50
Goodwill
6,142.50
Other Intangible Assets
3,342.00
Investments And Advances
26.90
Long Term Equity Investment
26.90
Non Current Deferred Assets
0.00
Non Current Deferred Taxes Assets
0.00
Other Non Current Assets
536.50
Total Liabilities Net Minority Interest
8,834.60
Current Liabilities
3,225.20
Payables And Accrued Expenses
1,200.10
Payables
955.00
Accounts Payable
827.50
Current Accrued Expenses
245.10
Employee Benefits
105.90
Pensionand Other Post Retirement Benefit Plans Current
431.40
Total Tax Payable
127.50
Current Debt And Capital Lease Obligation
1,172.00
Current Debt
999.80
Other Current Borrowings
1.10
Current Capital Lease Obligation
172.20
Current Deferred Liabilities
421.70
Current Deferred Revenue
421.70
Other Current Liabilities
—
Total Non Current Liabilities Net Minority Interest
5,609.40
Liabilities Heldfor Sale Non Current
0.00
Long Term Debt And Capital Lease Obligation
4,782.20
Long Term Debt
4,054.70
Long Term Capital Lease Obligation
727.50
Non Current Deferred Liabilities
525.30
Non Current Deferred Taxes Liabilities
417.90
Other Non Current Liabilities
142.30
Preferred Securities Outside Stock Equity
—
Stockholders Equity
7,875.00
Common Stock Equity
7,875.00
Capital Stock
7.70
Common Stock
7.70
Share Issued
83.90
Ordinary Shares Number
83.90
Treasury Shares Number
0.00
Additional Paid In Capital
38.40
Retained Earnings
7,888.20
Gains Losses Not Affecting Retained Earnings
-59.30
Minority Interest
15.50
Other Equity Adjustments
-59.30
Total Equity Gross Minority Interest
7,890.50
Total Capitalization
11,929.70
Working Capital
540.20
Invested Capital
12,929.50
Total Debt
5,954.20
Net Debt
4,517.70
Capital Lease Obligations
899.70
Net Tangible Assets
-1,609.50
Tangible Book Value
-1,609.50
Current Notes Payable
998.70
Derivative Product Liabilities
53.70
Line Of Credit
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
1,640.50
+3.45%
1,585.80
+19.44%
1,327.70
-32.12%
1,955.90
Cash Flow From Continuing Operating Activities
1,640.50
+3.45%
1,585.80
+31.90%
1,202.30
-31.87%
1,764.80
Cash From Discontinued Operating Activities
0.00
0.00
-100.00%
125.40
-34.38%
191.10
Net Income From Continuing Operations
877.70
+17.48%
747.10
+96.40%
380.40
-62.09%
1,003.50
Depreciation Amortization Depletion
681.10
+5.84%
643.50
+11.47%
577.30
+7.46%
537.20
Depreciation
401.10
+3.62%
387.10
+8.28%
357.50
+4.05%
343.60
Amortization Cash Flow
280.00
+9.20%
256.40
+16.65%
219.80
+13.53%
193.60
Depreciation And Amortization
681.10
+5.84%
643.50
+11.47%
577.30
+7.46%
537.20
Amortization Of Intangibles
280.00
+9.20%
256.40
+16.65%
219.80
+13.53%
193.60
Other Non Cash Items
380.10
+53.64%
247.40
+19.57%
206.90
+5.83%
195.50
Stock Based Compensation
125.80
+7.80%
116.70
-9.32%
128.70
+10.19%
116.80
Asset Impairment Charge
4.30
-18.87%
5.30
-98.48%
349.00
+33.36%
261.70
Deferred Tax
97.60
+585.57%
-20.10
+74.26%
-78.10
-396.96%
26.30
Deferred Income Tax
97.60
+585.57%
-20.10
+74.26%
-78.10
-396.96%
26.30
Change In Working Capital
-526.10
-241.40%
-154.10
+57.42%
-361.90
+3.80%
-376.20
Change In Receivables
-122.20
-457.99%
-21.90
+70.92%
-75.30
-425.97%
23.10
Changes In Account Receivables
-125.50
-139.96%
-52.30
+49.61%
-103.80
-323.23%
46.50
Change In Inventory
-30.20
-139.68%
-12.60
-1700.00%
-0.70
+98.46%
-45.50
Change In Prepaid Assets
-25.20
+53.76%
-54.50
-111.24%
-25.80
+89.43%
-244.10
Change In Payables And Accrued Expense
-383.10
-845.93%
-40.50
+88.92%
-365.60
-105.97%
-177.50
Change In Accrued Expense
-330.30
-193.34%
-112.60
+65.16%
-323.20
+30.18%
-462.90
Change In Payable
-52.80
-173.23%
72.10
+270.05%
-42.40
-114.86%
285.40
Change In Account Payable
-52.80
-173.23%
72.10
+270.05%
-42.40
-114.86%
285.40
Change In Other Working Capital
34.60
+240.65%
-24.60
-123.32%
105.50
+55.60%
67.80
Investing Cash Flow
-1,194.00
+12.64%
-1,366.80
-16.67%
-1,171.50
+29.09%
-1,652.20
Cash Flow From Continuing Investing Activities
-1,194.00
+12.64%
-1,366.80
-19.18%
-1,146.80
+28.31%
-1,599.60
Cash From Discontinued Investing Activities
0.00
0.00
+100.00%
-24.70
+53.04%
-52.60
Capital Expenditure
-434.50
+11.31%
-489.90
-8.00%
-453.60
-5.66%
-429.30
Capital Expenditure Reported
-434.50
+11.31%
-489.90
-8.00%
-453.60
-5.66%
-429.30
Net Investment Purchase And Sale
-192.40
-249.82%
-55.00
-89.66%
-29.00
-211.83%
-9.30
Purchase Of Investment
-192.40
-249.82%
-55.00
-89.66%
-29.00
-66.67%
-17.40
Sale Of Investment
—
0.00
-100.00%
6.70
-17.28%
8.10
Net Business Purchase And Sale
-575.10
+30.20%
-823.90
-23.93%
-664.80
+42.81%
-1,162.40
Purchase Of Business
-582.00
+30.63%
-839.00
-24.94%
-671.50
+42.31%
-1,164.00
Gain Loss On Sale Of Business
—
—
—
—
Net Other Investing Changes
8.00
+300.00%
2.00
+233.33%
0.60
-57.14%
1.40
Financing Cash Flow
-1,457.00
-286.82%
779.90
+1415.18%
-59.30
+95.52%
-1,322.20
Cash Flow From Continuing Financing Activities
-1,457.00
-286.82%
779.90
+150.03%
-1,559.00
-17.91%
-1,322.20
Net Issuance Payments Of Debt
-1,000.00
-200.00%
1,000.00
+433.33%
-300.00
0.00
Issuance Of Debt
64.80
-98.55%
4,463.70
+79.39%
2,488.20
+216.00%
787.40
Repayment Of Debt
-1,064.80
+69.26%
-3,463.70
-24.23%
-2,788.20
-254.10%
-787.40
Long Term Debt Issuance
64.80
-98.55%
4,463.70
+79.39%
2,488.20
+216.00%
787.40
Long Term Debt Payments
-1,064.80
+69.26%
-3,463.70
-24.23%
-2,788.20
-254.10%
-787.40
Net Long Term Debt Issuance
-1,000.00
-200.00%
1,000.00
+433.33%
-300.00
0.00
Short Term Debt Issuance
—
—
—
787.40
Short Term Debt Payments
—
—
—
-787.40
Net Short Term Debt Issuance
—
—
—
787.40
Net Common Stock Issuance
-450.00
-79.93%
-250.10
+74.99%
-1,000.00
+9.09%
-1,100.00
Common Stock Payments
-450.00
-79.93%
-250.10
+74.99%
-1,000.00
+9.09%
-1,100.00
Common Stock Dividend Paid
-240.70
+0.99%
-243.10
+4.29%
-254.00
-30.12%
-195.20
Cash Dividends Paid
-240.70
+0.99%
-243.10
+4.29%
-254.00
-30.12%
-195.20
Repurchase Of Capital Stock
-450.00
-79.93%
-250.10
+74.99%
-1,000.00
+9.09%
-1,100.00
Proceeds From Stock Option Exercised
54.30
-3.38%
56.20
+3.31%
54.40
+7.51%
50.60
Net Other Financing Charges
179.40
-17.29%
216.90
+465.15%
-59.40
+23.45%
-77.60
Changes In Cash
-1,010.50
-201.16%
998.90
+930.86%
96.90
+108.59%
-1,127.90
Effect Of Exchange Rate Changes
24.10
+241.76%
-17.00
-271.72%
9.90
+140.91%
-24.20
Beginning Cash Position
1,518.70
+182.92%
536.80
+24.84%
430.00
-70.80%
1,472.70
End Cash Position
532.30
-64.95%
1,518.70
+182.92%
536.80
+67.44%
320.60
Free Cash Flow
1,206.00
+10.05%
1,095.90
+25.37%
874.10
-42.74%
1,526.60
Interest Paid Supplemental Data
217.70
+4.06%
209.20
-5.55%
221.50
+12.61%
196.70
Income Tax Paid Supplemental Data
171.10
-20.57%
215.40
+4.16%
206.80
-56.45%
474.90
Common Stock Issuance
—
—
54.40
+7.51%
50.60
Issuance Of Capital Stock
—
—
54.40
+7.51%
50.60
Sale Of Business
6.90
-54.30%
15.10
+125.37%
6.70
+318.75%
1.60
Cash Flow From Discontinued Operation
—
0.00
0.00
+100.00%
-109.40
Cash From Discontinued Financing Activities
0.00
0.00
-100.00%
1,499.70
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category